Literature DB >> 27325474

Edema and Seed Displacements Affect Intraoperative Permanent Prostate Brachytherapy Dosimetry.

Hendrik Westendorp1, Tonnis T Nuver2, Carel J Hoekstra3, Marinus A Moerland4, André W Minken2.   

Abstract

PURPOSE: We sought to identify the intraoperative displacement patterns of seeds and to evaluate the correlation of intraoperative dosimetry with day 30 for permanent prostate brachytherapy. METHODS AND MATERIALS: We analyzed the data from 699 patients. Intraoperative dosimetry was acquired using transrectal ultrasonography (TRUS) and C-arm cone beam computed tomography (CBCT). Intraoperative dosimetry (minimal dose to 40%-95% of the volume [D40-D95]) was compared with the day 30 dosimetry for both modalities. An additional edema-compensating comparison was performed for D90. Stranded seeds were linked between TRUS and CBCT using an automatic and fast linking procedure. Displacement patterns were analyzed for each seed implantation location.
RESULTS: On average, an intraoperative (TRUS to CBCT) D90 decline of 10.6% ± 7.4% was observed. Intraoperative CBCT D90 showed a greater correlation (R(2) = 0.33) with respect to Day 30 than did TRUS (R(2) = 0.17). Compensating for edema, the correlation increased to 0.41 for CBCT and 0.38 for TRUS. The mean absolute intraoperative seed displacement was 3.9 ± 2.0 mm. The largest seed displacements were observed near the rectal wall. The central and posterior seeds showed less caudal displacement than lateral and anterior seeds. Seeds that were implanted closer to the base showed more divergence than seeds close to the apex.
CONCLUSIONS: Intraoperative CBCT D90 showed a greater correlation with the day 30 dosimetry than intraoperative TRUS. Edema seemed to cause most of the systematic difference between the intraoperative and day 30 dosimetry. Seeds near the rectal wall showed the most displacement, comparing TRUS and CBCT, probably because of TRUS probe-induced prostate deformation.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27325474     DOI: 10.1016/j.ijrobp.2016.04.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.

Authors:  Junghoon Lee; Omar Y Mian; Yi Le; Hee Joon Bae; E Clif Burdette; Theodore L DeWeese; Jerry L Prince; Daniel Y Song
Journal:  Radiother Oncol       Date:  2017-06-21       Impact factor: 6.280

2.  Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging.

Authors:  Geoffrey V Martin; Thomas J Pugh; Usama Mahmood; Rajat J Kudchadker; Jihong Wang; Teresa L Bruno; Tharakeswara Bathala; Steven J Frank
Journal:  Brachytherapy       Date:  2017-03-09       Impact factor: 2.362

3.  Superior Postimplant Dosimetry Achieved Using Dynamic Intraoperative Dosimetry for Permanent Prostate Brachytherapy.

Authors:  Tanmay Singh; Junghoon Lee; Marianna Zahurak; Hee Joon Bae; Tamey Habtu; Robert Hobbs; Yi Le; Everette C Burdette; Daniel Y Song
Journal:  Pract Radiat Oncol       Date:  2021-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.